Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.

Ankle bones and joint © SHUTTERSTOCK

Total ankle replacement is one of the less commonly known joint replacement surgeries compared to hip or knee replacement. It was first introduced in the early 1970s for the surgical management of ankle trauma and end-stage osteoarthritis (OA). But early outcomes for OA were poor and clinicians continued to use an established technique called ankle arthrodesis, where the bones of the ankle were fused together. This technique wasn't without its difficulties and patients would often experience the loss of mobility, pain, disability, and the potential for OA at adjacent joints.

It wasn't until the 1980s-90s that total ankle arthroplasty, or more commonly called total ankle replacement (TAR), became more widely used following improved postoperative outcomes. Despite evidence supporting improvement following ankle replacement, it remained unclear as to how much TAR has been adopted globally for the treatment of ankle trauma and primary or secondary arthritis.

Dr Thomas Perry, co-lead author and postdoctoral researcher at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford said: "In the fields of rheumatology and orthopaedics, very rarely do you hear of total ankle replacements. More so, in the context of osteoarthritis, you only typically hear of hip and knee replacements. Why is this the case? Well, currently, there are no clear guidelines for the management of ankle OA, there are several indications for ankle replacement outside of OA including trauma and rheumatoid arthritis and, it takes time to introduce new surgical procedures at a national level. The aims of the study were to better understand why people are having ankle replacements, to examine potential barriers to adoption of ankle replacements and to help predict future requirements."

A collaboration between researchers from Australia, Finland, New Zealand, Norway, Sweden and the UK, the study has been published in the Foot and Ankle International journal. It recorded and compared annual rates of primary ankle replacements between national joint registries for the period 1993 to 2019, and examined sources of variation. Globally, there are just six arthroplasty registries collecting national data on primary ankle replacements and this study utilised all available data from these registries.

The study found that:

  • For the period with data from all 6 countries (2010-2015), New Zealand had the largest annual incidence of ankle replacement procedures per 100,000 population, whereas Finland had the lowest incidence.
  • OA was the predominant diagnosis for ankle replacement in the UK, Australia and New Zealand.
  • RA was the most common indication in Scandinavia.
  • There were no common temporal trends in the utilisation of ankle replacements but there were marked differences with their utilisation.

"The majority of the six registries initially showed an exponential growth in ankle replacements from registry inception. We explored potential reasons for this growth including data completeness, speed of national adoption, whether data collection was voluntary/mandatory etc. Of the 6 registries, 5 showed a year of peak incidence and from this point, we then saw varying rates of decline. Understanding the reasons for such divergence is critical to understanding whether the current surgical demands for ankle replacement are being met," said Thomas.

Annual incidence of primary ankle replacement (all diagnoses) for six countries.        5-year moving averages for the annual incidence rates of ankle replacements per 100,000 population for entire registry period.Annual incidence of primary ankle replacement (all diagnoses) for six countries. 5-year moving averages for the annual incidence rates of ankle replacements per 100,000 population for entire registry period.

Professor Alan Silman, co-author and Professor of Musculoskeletal Health at NDORMS said: "It's fascinating that it has been so variable between countries. It's now important to explore the cause of the decline. The incidence of RA is going down globally with better treatments, but osteoarthritis and trauma are becoming more common. Or could the decline be something more to do with policy or funding? The challenge is to ensure there is enough capacity in a country to perform this surgery."

Rates for primary ankle replacement by OA disease in 6 countriesRates for primary ankle replacement by OA disease in 6 countries

Primary ankle replacement by RA disease in 6 countriesPrimary ankle replacement by RA disease in 6 countries

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.